Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
05/2006
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/16/2006US7045652 Processes for preparing substituted aryl boronic acids
05/16/2006US7045541 Compounds for the treatment of metabolic disorders
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006CA2195724C Process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
05/11/2006WO2006049860A1 Organic element for electroluminescent devices
05/11/2006WO2006049182A1 Hydroxyalkylated polyalkylenepolyamine composition, method for producing same and method for producing polyurethane resin using such hydroxyalkylated polyalkylenepolyamine composition
05/11/2006WO2006049014A1 PROCESS FOR PRODUCING α,α-DIFLUOROAMINE
05/11/2006US20060100463 Selective hydrogenation of nitrogen containing aromatics
05/11/2006US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
05/11/2006US20060100250 Biphenyl derivatives and their use as fungicides
05/10/2006EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
05/10/2006CN1769262A 2-butyl -3-(4 -[3(dibutylamino) propoxy]benzoyl) -5-nitro -benzofuran hydrochloride and preparation thereof.
05/10/2006CN1769261A Cation hydrophobic monomer preparation
05/10/2006CN1255392C Colchinol derivatives as angiogenesis inhibitors
05/10/2006CN1255365C Fluorene compound and organic lumnescent device using the same
05/09/2006US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained
05/09/2006US7041659 Compounds for the treatment of metabolic disorders
05/04/2006WO2006046593A1 Benzene compound having 2 or more substituents
05/04/2006WO2006045519A1 Synthesis of phenoxyacetic acid derivatives
05/04/2006CA2585037A1 Synthesis of phenoxyacetic acid derivatives
05/03/2006CN1765891A Novel aryloxy-alkyl-dialkylamines compound
05/03/2006CN1254465C Calcilytic compounds
05/02/2006USRE39088 Amide compounds and use of the same
05/02/2006US7038078 Forming allyloxycarbonyl-, fluorenylmethoxycarbonyl-, t-butoxycarbonyl- and benzyloxycarbonyl derivatives by aziding (chloroethoxy)ethoxyethanol, reacting with triphenyl phosphine and H2O, reacting with a chloroformate, oxidizing
05/02/2006US7038075 Production method of racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid C1-6 alkyl ester
05/02/2006US7038073 Synthesis of 2-alkyl amino acids
05/02/2006US7037938 For therapy of urinary incontinence
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease
05/02/2006CA2256559C N-bis- or n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amine derivatives and preparation and use of the same
04/2006
04/27/2006WO2006043577A1 Method for producing phenylethanolamine compound and intermediate thereof
04/27/2006US20060089500 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds
04/26/2006EP1650184A1 Mixtures of N,N-Bis-(2-hydroxyalkyl)-4-toluidin, their preparation and use
04/26/2006EP1648855A2 Levalbuterol hydrochloride polymorph a
04/25/2006US7033401 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
04/20/2006WO2006041115A1 Fluorine-containing polymerizable monomer and polymer compound using same
04/20/2006WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent
04/20/2006WO2006004923A3 Enantiomerically pure atomoxetine and tomoxetine mandelate
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance
04/20/2006US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/20/2006US20060083780 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity
04/20/2006US20060083680 Diphenyl ether derivatives and their use for imaging serotonin transporters
04/20/2006US20060082294 Organic electroluminescence device and phenylenediamine derivative
04/19/2006EP1646606A1 2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof
04/19/2006CN1252034C Amine compound and organic electroluminescence element using the same
04/19/2006CN1251671C Beta secretase inhibitors
04/18/2006US7030276 reacting 2-[(dimethylamino)methyl]-cyclohexanone in a Grignard reaction with a Grignard compound of 3-bromoanisole in a suitable solvent and in the presence of an inorganic lithium salt and an alpha , omega -dialkoxyalkane; high stereoselectivity and high yield
04/18/2006US7030256 Metal-ligand complexes has a dianionic ligand chelating to the metal; non-metallocene group 4 complexes as polymerization catalyst for preparing isotactic polypropylene, or copolymers of ethylene/olefin; high molecular weight polypropylene with a high melting point
04/18/2006US7030164 This invention relates to a highly thermally stable novel anhydrous crystalline polymorphic form of venlafaxine hydrochloride, methods for the preparation thereof, and its use.
04/18/2006US7030067 For phosphate ester hydraulic fluids used in conditions under which hydrocarbon surfactants would degrade
04/13/2006WO2006004979A3 An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
04/13/2006WO2006004977A3 Process for the optical resolution and recycling of tomoxetine
04/13/2006US20060079719 Aminated compounds bearing at least an allyl and a difluoromethyl and method used for synthesis thereof
04/13/2006US20060079581 Polymorphs of atomoxetine hydrochloride
04/12/2006EP1645614A1 Preparation of amine derivates from nitriles and phenols
04/12/2006EP1643834A1 Surfactant compounds and agrochemical compositions
04/12/2006EP1418879B1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
04/12/2006EP1311499B1 Bicyclic compounds as h3 receptor ligands
04/12/2006EP1311471B1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
04/12/2006CN1758925A Methods of radiofluorination of biologically active vectors
04/12/2006CN1757620A Biphase identification chiral prepn. of chromatographic chiral compound(s)
04/11/2006US7026518 Catechol and/or pyrogallol moieties, e.g., 5-[(1E)-2-(3,4-dihydroxyphenyl)vinyl]-benzene1,2,3-triol, and trihydroxybenzoyl derivatives; improved bioprotecctive properties; free radical scavengers; oxidation resistance; anticarcinogenic and -inflammation agents; cardiovascular disorders; food processing
04/11/2006US7026513 Manufacture of phenyl ethylamine compounds, in particular venlafaxine
04/11/2006US7026512 Tertiary alkanolamines containing surface active alkyl groups
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006CA2198383C Benzene compound and pharmaceutical use thereof
04/11/2006CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
04/06/2006WO2006035685A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same
04/06/2006WO2006035457A1 A process for the manufacture of venlafaxine and intermediates thereof
04/06/2006US20060074131 Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
04/06/2006US20060074111 Chemical compounds
04/05/2006EP1641741A1 Levalbuterol hydrochloride polymorph b
04/05/2006EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
04/05/2006EP1041976B1 Polyamide oligomers
04/05/2006CN1756733A Process for preparation of phenethylamine derivatives
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249038C Process for preparing aryl ether
04/05/2006CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
04/05/2006CN1249018C Triaryl methane compounds for sickle cell disease
04/04/2006US7022739 Substituted 1-aminobutan-3-ol compounds
04/04/2006US7021697 Vehicle and a vehicle door
03/2006
03/30/2006WO2006033318A1 Cyclic amine derivative or salt thereof
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/30/2006CA2581342A1 Alkoxylated alkylamines / alkyl ether amines with peaked distribution
03/30/2006CA2577799A1 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
03/29/2006EP1265483B1 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces
03/29/2006CN1752089A Preparation method of high melting point 3-dibutylamino-6-methyl-7-anilino fluorane
03/29/2006CN1247523C Substituted 1 and 2 naphthol mannich bases
03/28/2006US7019045 Amino group containing phenol
03/28/2006US7019031 By deactivation of the prenylation enzyme through covalent modification; method for screening for cancer drugs by ability to inhibit prenylation
03/28/2006US7018797 Method for treating neurodegenerative disorders
03/23/2006WO2005040102A3 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060061265 Aromatic amine derivative and organic electroluminescent element employing the same
03/23/2006DE102004042418A1 Verfahren zur Reinigung von Gasen A process for the purification of gases
03/22/2006EP1637210A1 Process for purifying gases and absorbent therefor
03/22/2006EP1636171A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 140